首页 > 最新文献

Critical Care Research and Practice最新文献

英文 中文
The Hemodynamic Management and Postoperative Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Prospective Observational Study.
IF 1.8 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-12-27 eCollection Date: 2024-01-01 DOI: 10.1155/ccrp/8815211
Sohan Lal Solanki, Vandana Agarwal, Reshma P Ambulkar, Malini P Joshi, Shreyas Chawathey, Shivacharan Patel Rudrappa, Manish Bhandare, Avanish P Saklani

Background: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) has become standard treatment for peritoneal cancers and metastases, significantly enhancing survival rates. This study evaluated the relationship between tumor burden, hemodynamic management, and postoperative outcomes after CRS-HIPEC. Methodology: This study included 203 patients undergoing CRS-HIPEC. The study was registered with ClinicalTrials.gov (NCT02754115). Routine and advanced hemodynamic monitoring was performed. Data on fluid and blood transfusions, coagulation management, body temperature, blood gases, Peritoneal Carcinomatosis Index (PCI), and chemotherapeutic agents used were collected. Postoperatively, complications using the Clavien-Dindo classification were employed. Primary outcomes assessed PCI's impact on hemodynamic parameters and fluid management, with secondary outcomes including postoperative complications, mortality, and length of ICU and hospital stays. Results: Patients with PCI > 20 experienced significantly longer surgeries (796.2 ± 158.3 min) as compared with patients with PCI 0-10 (551 ± 127 min) and patients with PCI between 11 and 20 (661.78 ± 137.7 min) (p ≤ 0.01). Patients with PCI > 20 received higher fluid requirements (mean: 5497.7 ± 2401.9 mL) as compared with PCI 0-10 (2631.2 ± 1459.9 mL) and PCI 10-20 (3964.65 ± 2044.6 mL) (p ≤ 0.01). Patients with PCI > 20 also had a prolonged ICU stays (median: 4 days) as compared with PCI 0-20 (median: 3 days). However, these differences were not significant in patients with PCI between 10 and 20. Significant differences in CI and SVI were observed among PCI groups during and after HIPEC. Significant differences were also observed among PCI groups for postoperative complications. Although 30-day survival rates varied clinically, they did not reach statistical significance. Conclusion: A higher PCI score was significantly associated with increased duration of surgery, fluid requirements, the need for invasive hemodynamic monitoring, postoperative complications, and longer ICU stays. Tailoring perioperative strategies based on PCI scores has the potential to optimize these outcomes. Trial Registration: ClinicalTrials.gov identifier: NCT02754115.

{"title":"The Hemodynamic Management and Postoperative Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Prospective Observational Study.","authors":"Sohan Lal Solanki, Vandana Agarwal, Reshma P Ambulkar, Malini P Joshi, Shreyas Chawathey, Shivacharan Patel Rudrappa, Manish Bhandare, Avanish P Saklani","doi":"10.1155/ccrp/8815211","DOIUrl":"https://doi.org/10.1155/ccrp/8815211","url":null,"abstract":"<p><p><b>Background:</b> Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) has become standard treatment for peritoneal cancers and metastases, significantly enhancing survival rates. This study evaluated the relationship between tumor burden, hemodynamic management, and postoperative outcomes after CRS-HIPEC. <b>Methodology:</b> This study included 203 patients undergoing CRS-HIPEC. The study was registered with ClinicalTrials.gov (NCT02754115). Routine and advanced hemodynamic monitoring was performed. Data on fluid and blood transfusions, coagulation management, body temperature, blood gases, Peritoneal Carcinomatosis Index (PCI), and chemotherapeutic agents used were collected. Postoperatively, complications using the Clavien-Dindo classification were employed. Primary outcomes assessed PCI's impact on hemodynamic parameters and fluid management, with secondary outcomes including postoperative complications, mortality, and length of ICU and hospital stays. <b>Results:</b> Patients with PCI > 20 experienced significantly longer surgeries (796.2 ± 158.3 min) as compared with patients with PCI 0-10 (551 ± 127 min) and patients with PCI between 11 and 20 (661.78 ± 137.7 min) (<i>p</i> ≤ 0.01). Patients with PCI > 20 received higher fluid requirements (mean: 5497.7 ± 2401.9 mL) as compared with PCI 0-10 (2631.2 ± 1459.9 mL) and PCI 10-20 (3964.65 ± 2044.6 mL) (<i>p</i> ≤ 0.01). Patients with PCI > 20 also had a prolonged ICU stays (median: 4 days) as compared with PCI 0-20 (median: 3 days). However, these differences were not significant in patients with PCI between 10 and 20. Significant differences in CI and SVI were observed among PCI groups during and after HIPEC. Significant differences were also observed among PCI groups for postoperative complications. Although 30-day survival rates varied clinically, they did not reach statistical significance. <b>Conclusion:</b> A higher PCI score was significantly associated with increased duration of surgery, fluid requirements, the need for invasive hemodynamic monitoring, postoperative complications, and longer ICU stays. Tailoring perioperative strategies based on PCI scores has the potential to optimize these outcomes. <b>Trial Registration:</b> ClinicalTrials.gov identifier: NCT02754115.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2024 ","pages":"8815211"},"PeriodicalIF":1.8,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698608/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of COVID-19 Treatments in Intensive Care Unit: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
IF 1.8 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-11-27 eCollection Date: 2024-01-01 DOI: 10.1155/ccrp/2973795
Mahmoud Alwakeel, Francois Abi Fadel, Abdelrahman Nanah, Yan Wang, Mohamed K A Awad, Fatima Abdeljaleel, Mohammed Obeidat, Talha Saleem, Saira Afzal, Dina Alayan, Mary Pat Harnegie, Xiaofeng Wang, Abhijit Duggal, Peng Zhang

Objectives: Examining the cumulative evidence from randomized controlled trials (RCTs), evaluating the use of pharmacological agents for the treatment of COVID-19 infections in patients with critical illness. Data Sources: Databases Medline, Embase, Web of Science, Scopus, CINAHL, and Cochrane. Study Selection: Inclusion criteria were RCTs that enrolled patients with confirmed or suspected COVID-19 infection who are critically ill. Only RCTs that examined therapeutic agents against one another or no intervention, placebo, or standard of care, were included. Data Extraction: Pairs of reviewers extracted data independently. Outcomes of interest included the overall reported mortality defined as either the ICU mortality, hospital mortality, mortality within 28 days or mortality within 90 days. Data Synthesis: A total of 40 studies (11,613 patients) evaluated 50 therapeutic intervention arms divided into five main therapy categories; steroids, antiviral medications, immunomodulators, plasma therapies [intravenous immunoglobulins (IVIG), convalescent plasma and/or, therapeutic plasma exchange], and therapeutic anticoagulation. Immunomodulators was the only group with possible mortality benefit, risk ratio (RR) 0.83 (95% CI 0.73; 0.95), with nonsignificant heterogeneity (I 2 = 8%, p=0.36). In contrast, the other therapy groups showed no significant impact on mortality, as indicated by their respective pooled RRs: steroids [RR 0.91 (95% CI 0.82; 1.01), I 2 = 31%], antiviral medications [RR 1.11 (95% CI 0.82; 1.49), I 2 = 57%], plasma therapies [RR 0.77 (95% CI 0.58; 1.01), I 2 = 36%], and anticoagulation [RR 1.06 (95% CI 0.95; 1.18), I 2 = 0%]. Conclusions: This meta-analysis highlights both the heterogeneity and a lack of benefit from therapies evaluated during the COVID-19 pandemic. Many of the RCTs were developed based on limited observational data. Future RCTs investigating pharmaceutical interventions in critically ill patients during pandemics need to be designed based on better evidence.

{"title":"Efficacy of COVID-19 Treatments in Intensive Care Unit: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.","authors":"Mahmoud Alwakeel, Francois Abi Fadel, Abdelrahman Nanah, Yan Wang, Mohamed K A Awad, Fatima Abdeljaleel, Mohammed Obeidat, Talha Saleem, Saira Afzal, Dina Alayan, Mary Pat Harnegie, Xiaofeng Wang, Abhijit Duggal, Peng Zhang","doi":"10.1155/ccrp/2973795","DOIUrl":"10.1155/ccrp/2973795","url":null,"abstract":"<p><p><b>Objectives:</b> Examining the cumulative evidence from randomized controlled trials (RCTs), evaluating the use of pharmacological agents for the treatment of COVID-19 infections in patients with critical illness. <b>Data Sources:</b> Databases Medline, Embase, Web of Science, Scopus, CINAHL, and Cochrane. Study Selection: Inclusion criteria were RCTs that enrolled patients with confirmed or suspected COVID-19 infection who are critically ill. Only RCTs that examined therapeutic agents against one another or no intervention, placebo, or standard of care, were included. <b>Data Extraction:</b> Pairs of reviewers extracted data independently. Outcomes of interest included the overall reported mortality defined as either the ICU mortality, hospital mortality, mortality within 28 days or mortality within 90 days. <b>Data Synthesis:</b> A total of 40 studies (11,613 patients) evaluated 50 therapeutic intervention arms divided into five main therapy categories; steroids, antiviral medications, immunomodulators, plasma therapies [intravenous immunoglobulins (IVIG), convalescent plasma and/or, therapeutic plasma exchange], and therapeutic anticoagulation. Immunomodulators was the only group with possible mortality benefit, risk ratio (RR) 0.83 (95% CI 0.73; 0.95), with nonsignificant heterogeneity (<i>I</i> <sup>2</sup> = 8%, <i>p</i>=0.36). In contrast, the other therapy groups showed no significant impact on mortality, as indicated by their respective pooled RRs: steroids [RR 0.91 (95% CI 0.82; 1.01), <i>I</i> <sup>2</sup> = 31%], antiviral medications [RR 1.11 (95% CI 0.82; 1.49), <i>I</i> <sup>2</sup> = 57%], plasma therapies [RR 0.77 (95% CI 0.58; 1.01), <i>I</i> <sup>2</sup> = 36%], and anticoagulation [RR 1.06 (95% CI 0.95; 1.18), <i>I</i> <sup>2</sup> = 0%]. <b>Conclusions:</b> This meta-analysis highlights both the heterogeneity and a lack of benefit from therapies evaluated during the COVID-19 pandemic. Many of the RCTs were developed based on limited observational data. Future RCTs investigating pharmaceutical interventions in critically ill patients during pandemics need to be designed based on better evidence.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2024 ","pages":"2973795"},"PeriodicalIF":1.8,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11617054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Satisfaction Levels Among Families of Intensive Care Unit Patients in Saudi Arabia: A Cross-Sectional Study. 沙特阿拉伯重症监护病房患者家属满意度评估:一项横断面研究
IF 1.8 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-10-23 eCollection Date: 2024-01-01 DOI: 10.1155/2024/8481083
Abdullah Shbeer, Mohammed Ageel

Background: Regularly measuring family satisfaction with intensive care unit (ICU) experience is crucial for ensuring high-quality care and identifying areas for improvement. This study aimed to evaluate family satisfaction with the ICU in Saudi Arabia. Methods: A cross-sectional survey was conducted among 248 family members of patients admitted to various ICUs. The survey assessed family satisfaction via a validated questionnaire, the Critical Care Family Satisfaction Survey (CCFSS), which includes five subscales: assurance, information, comfort, proximity, and support. Demographic data were also collected. Descriptive and inferential statistics were calculated. Results: The demographic distribution revealed that a majority of the participants were female (70.97%, n = 176), with the relationships with the patients predominantly being parents (41.94%, n = 104) or offspring (33.87%, n = 84). The overall satisfaction score was 3.79 ± 1.26, with 66.13% of the participants reporting high satisfaction, 20.97% reporting intermediate satisfaction, and 12.90% reporting low satisfaction. The mean subscale scores were as follows: assurance (3.82 ± 1.2), information (3.83 ± 1.25), comfort (3.81 ± 1.27), proximity (3.72 ± 1.28), and support (3.78 ± 1.28). The highest satisfaction scores were observed for sharing in decisions, noise levels, and staff honesty, whereas the lowest scores were for visiting hours flexibility, transfer preparation, and staff responsiveness. Males reported significantly greater satisfaction (4.24 ± 1.20) than females did (3.61 ± 1.11, p = 0.007). Conclusions: This study revealed moderate to high levels of family satisfaction with the ICU, with significant differences based on sex. The findings highlight the importance of effective communication, family involvement in decision-making, and supportive ICU policies. ICUs should regularly assess family satisfaction and use the results to guide quality improvement efforts, with a focus on areas with lower satisfaction scores.

背景:定期测量家属对重症监护病房(ICU)体验的满意度对于确保高质量护理和确定需要改进的方面至关重要。本研究旨在评估沙特阿拉伯重症监护病房的家属满意度。方法:对入住不同重症监护病房的 248 名患者家属进行了横向调查。调查通过一份经过验证的问卷--重症监护家属满意度调查(CCFSS)来评估家属的满意度,该问卷包括五个分量表:保证、信息、舒适、接近和支持。此外,还收集了人口统计学数据。计算了描述性和推论性统计数据。结果人口统计学分布显示,大多数参与者为女性(70.97%,n = 176),与患者的关系主要是父母(41.94%,n = 104)或后代(33.87%,n = 84)。总体满意度为 3.79 ± 1.26 分,66.13% 的参与者表示高度满意,20.97% 表示中度满意,12.90% 表示低度满意。各分量表的平均得分如下:保证(3.82 ± 1.2)、信息(3.83 ± 1.25)、舒适(3.81 ± 1.27)、接近(3.72 ± 1.28)和支持(3.78 ± 1.28)。满意度最高的是共同决策、噪音水平和工作人员的诚实,而满意度最低的是探视时间的灵活性、转院准备和工作人员的反应能力。男性的满意度(4.24 ± 1.20)明显高于女性(3.61 ± 1.11,p = 0.007)。结论:本研究显示,家属对重症监护室的满意度为中高水平,但性别差异显著。研究结果凸显了有效沟通、家属参与决策和 ICU 支持性政策的重要性。重症监护室应定期评估家属满意度,并利用评估结果指导质量改进工作,重点关注满意度较低的领域。
{"title":"Assessment of Satisfaction Levels Among Families of Intensive Care Unit Patients in Saudi Arabia: A Cross-Sectional Study.","authors":"Abdullah Shbeer, Mohammed Ageel","doi":"10.1155/2024/8481083","DOIUrl":"10.1155/2024/8481083","url":null,"abstract":"<p><p><b>Background:</b> Regularly measuring family satisfaction with intensive care unit (ICU) experience is crucial for ensuring high-quality care and identifying areas for improvement. This study aimed to evaluate family satisfaction with the ICU in Saudi Arabia. <b>Methods:</b> A cross-sectional survey was conducted among 248 family members of patients admitted to various ICUs. The survey assessed family satisfaction via a validated questionnaire, the Critical Care Family Satisfaction Survey (CCFSS), which includes five subscales: assurance, information, comfort, proximity, and support. Demographic data were also collected. Descriptive and inferential statistics were calculated. <b>Results:</b> The demographic distribution revealed that a majority of the participants were female (70.97%, <i>n</i> = 176), with the relationships with the patients predominantly being parents (41.94%, <i>n</i> = 104) or offspring (33.87%, <i>n</i> = 84). The overall satisfaction score was 3.79 ± 1.26, with 66.13% of the participants reporting high satisfaction, 20.97% reporting intermediate satisfaction, and 12.90% reporting low satisfaction. The mean subscale scores were as follows: assurance (3.82 ± 1.2), information (3.83 ± 1.25), comfort (3.81 ± 1.27), proximity (3.72 ± 1.28), and support (3.78 ± 1.28). The highest satisfaction scores were observed for sharing in decisions, noise levels, and staff honesty, whereas the lowest scores were for visiting hours flexibility, transfer preparation, and staff responsiveness. Males reported significantly greater satisfaction (4.24 ± 1.20) than females did (3.61 ± 1.11, <i>p</i> = 0.007). <b>Conclusions:</b> This study revealed moderate to high levels of family satisfaction with the ICU, with significant differences based on sex. The findings highlight the importance of effective communication, family involvement in decision-making, and supportive ICU policies. ICUs should regularly assess family satisfaction and use the results to guide quality improvement efforts, with a focus on areas with lower satisfaction scores.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2024 ","pages":"8481083"},"PeriodicalIF":1.8,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11524694/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum Concentration at 24 h With Intensive Beta-Lactam Therapy in Sepsis and Septic Shock: A Prospective Study: Beta-Lactam Blood Levels in Sepsis. 脓毒症和脓毒性休克患者接受强化β-内酰胺治疗 24 小时后的血清浓度:一项前瞻性研究:败血症中的β-内酰胺血药浓度。
IF 1.8 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-10-21 eCollection Date: 2024-01-01 DOI: 10.1155/2024/9757792
Evelyne Thériault, Massilia Benali, Samuel Starnino, Hugues Blain, Nicolas Goettel, Bianca Beloin-Jubinville, Amélie Marsot, Francois Lamontagne

Introduction: Early administration of appropriate antibiotics has been shown to be among the most effective interventions to reduce mortality in septic patients. We evaluated the attainment of efficacy and safety targets at 24 h associated with the use of intensive beta-lactam therapy in patients admitted to the intensive care unit for sepsis. Methods: This was a prospective study with patients who received beta-lactams for sepsis or septic shock between February 2023 and September 2023. The antibiotic dose was unadjusted for renal function and administered by a loading dose followed by extended infusions, according to local practices. Blood samples were taken at the trough 24 h after the start of the beta-lactam to obtain serum levels. These levels were compared to efficacy and innocuity thresholds found in the literature. Results: Among 36 included patients, all of them achieved serum concentrations above the minimum inhibitory concentration (MIC) for 100% of the therapeutic interval and 75% of them achieved serum concentrations above four times the MIC for 100% of the therapeutic interval. The predefined toxicity thresholds were reached by 8.3% of patients. Renal impairment was the factor most associated with the achievement of higher serum levels. Conclusion: Nonrenally adjusted doses of beta-lactams administered by extended infusion showed good attainment of effective concentrations and few toxic concentrations in critically ill patients with sepsis or septic shock. Further studies are needed to better define the association between toxic concentrations and toxicity manifestations.

导言:事实证明,尽早使用适当的抗生素是降低脓毒症患者死亡率的最有效干预措施之一。我们对因脓毒症入住重症监护室的患者在 24 小时内使用强化β-内酰胺类药物治疗的疗效和安全性目标的实现情况进行了评估。研究方法这是一项前瞻性研究,研究对象为 2023 年 2 月至 2023 年 9 月期间因脓毒症或脓毒性休克而接受β-内酰胺类药物治疗的患者。抗生素剂量未根据肾功能进行调整,并按照当地惯例先给予负荷剂量,然后延长输液时间。在开始使用β-内酰胺类药物 24 小时后的低谷期采集血样,以获得血清水平。将这些水平与文献中的疗效阈值和无害阈值进行比较。结果:在纳入的 36 名患者中,所有患者的血清浓度在 100%的治疗间隔期内均高于最低抑菌浓度(MIC),其中 75% 的患者的血清浓度在 100%的治疗间隔期内均高于 MIC 的四倍。8.3%的患者达到了预定的毒性阈值。肾功能损害是导致血清浓度升高的最主要因素。结论在脓毒症或脓毒性休克的重症患者中,通过延长输注给予非肾功能调整剂量的β-内酰胺类药物能很好地达到有效浓度,且毒性浓度较低。需要进一步研究以更好地确定毒性浓度与毒性表现之间的关联。
{"title":"Serum Concentration at 24 h With Intensive Beta-Lactam Therapy in Sepsis and Septic Shock: A Prospective Study: Beta-Lactam Blood Levels in Sepsis.","authors":"Evelyne Thériault, Massilia Benali, Samuel Starnino, Hugues Blain, Nicolas Goettel, Bianca Beloin-Jubinville, Amélie Marsot, Francois Lamontagne","doi":"10.1155/2024/9757792","DOIUrl":"https://doi.org/10.1155/2024/9757792","url":null,"abstract":"<p><p><b>Introduction:</b> Early administration of appropriate antibiotics has been shown to be among the most effective interventions to reduce mortality in septic patients. We evaluated the attainment of efficacy and safety targets at 24 h associated with the use of intensive beta-lactam therapy in patients admitted to the intensive care unit for sepsis. <b>Methods:</b> This was a prospective study with patients who received beta-lactams for sepsis or septic shock between February 2023 and September 2023. The antibiotic dose was unadjusted for renal function and administered by a loading dose followed by extended infusions, according to local practices. Blood samples were taken at the trough 24 h after the start of the beta-lactam to obtain serum levels. These levels were compared to efficacy and innocuity thresholds found in the literature. <b>Results:</b> Among 36 included patients, all of them achieved serum concentrations above the minimum inhibitory concentration (MIC) for 100% of the therapeutic interval and 75% of them achieved serum concentrations above four times the MIC for 100% of the therapeutic interval. The predefined toxicity thresholds were reached by 8.3% of patients. Renal impairment was the factor most associated with the achievement of higher serum levels. <b>Conclusion:</b> Nonrenally adjusted doses of beta-lactams administered by extended infusion showed good attainment of effective concentrations and few toxic concentrations in critically ill patients with sepsis or septic shock. Further studies are needed to better define the association between toxic concentrations and toxicity manifestations.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2024 ","pages":"9757792"},"PeriodicalIF":1.8,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519078/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Impact of Simulation-Based Learning on Student Satisfaction and Self-Confidence in Critical Care Medicine. 评估模拟学习对重症医学专业学生满意度和自信心的影响。
IF 1.8 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-10-18 eCollection Date: 2024-01-01 DOI: 10.1155/2024/6908005
Mohammed Ageel

Background: Simulation-based learning (SBL) is increasingly used in medical education to prepare students for clinical practice. This study aimed to evaluate the satisfaction and self-confidence of final-year medical students after attending SBL in critical care medicine. Methods: A cross-sectional study was conducted among 117 final-year medical students at Jazan University, Saudi Arabia. Participants attended SBL sessions focusing on critical care skills and scenarios. Data were collected using a self-administered questionnaire, which included demographic information and the Student Satisfaction and Self-Confidence in Learning Scale. Statistical analyses included descriptive and inferential statistics. Results: The study population comprised 61.54% females and 38.46% males, with a majority aged 24 years. Students who rated their overall learning experience as "Good" showed significantly higher satisfaction (4.20 ± 0.77) and self-confidence (4.20 ± 0.69) scores. The overall mean scores for satisfaction and self-confidence were 3.71 ± 0.88 and 3.70 ± 0.87, respectively. A strong positive correlation (p < 0.001) was found between satisfaction and self-confidence levels. The highest satisfaction and self-confidence scores were associated with the variety of learning materials and the instructors' helpfulness. Conclusion: The SBL intervention was effective in enhancing student satisfaction and self-confidence in critical care medicine. The strong correlation between satisfaction and self-confidence highlights the importance of well-designed SBL programs in preparing medical students for clinical practice in critical care settings.

背景:医学教育中越来越多地使用模拟学习(SBL)来帮助学生为临床实践做好准备。本研究旨在评估重症医学专业应届医学生参加 SBL 后的满意度和自信心。研究方法在沙特阿拉伯贾赞大学的 117 名应届医学生中开展了一项横断面研究。参与者参加了以重症监护技能和情景为重点的 SBL 课程。研究采用自填式问卷收集数据,其中包括人口统计学信息和学生满意度与学习自信心量表。统计分析包括描述性统计和推论性统计。研究结果研究对象中女性占 61.54%,男性占 38.46%,年龄大多为 24 岁。总体学习体验被评为 "好 "的学生的满意度(4.20 ± 0.77)和自信心(4.20 ± 0.69)得分明显更高。满意度和自信心的总平均分分别为 3.71 ± 0.88 和 3.70 ± 0.87。满意度和自信心水平之间存在很强的正相关性(p < 0.001)。满意度和自信心得分最高的是学习材料的多样性和教师的乐于助人。结论SBL 干预能有效提高重症医学专业学生的满意度和自信心。满意度和自信心之间的强相关性凸显了精心设计的 SBL 课程在帮助医学生为重症医学临床实践做好准备方面的重要性。
{"title":"Assessing the Impact of Simulation-Based Learning on Student Satisfaction and Self-Confidence in Critical Care Medicine.","authors":"Mohammed Ageel","doi":"10.1155/2024/6908005","DOIUrl":"10.1155/2024/6908005","url":null,"abstract":"<p><p><b>Background:</b> Simulation-based learning (SBL) is increasingly used in medical education to prepare students for clinical practice. This study aimed to evaluate the satisfaction and self-confidence of final-year medical students after attending SBL in critical care medicine. <b>Methods:</b> A cross-sectional study was conducted among 117 final-year medical students at Jazan University, Saudi Arabia. Participants attended SBL sessions focusing on critical care skills and scenarios. Data were collected using a self-administered questionnaire, which included demographic information and the Student Satisfaction and Self-Confidence in Learning Scale. Statistical analyses included descriptive and inferential statistics. <b>Results:</b> The study population comprised 61.54% females and 38.46% males, with a majority aged 24 years. Students who rated their overall learning experience as \"Good\" showed significantly higher satisfaction (4.20 ± 0.77) and self-confidence (4.20 ± 0.69) scores. The overall mean scores for satisfaction and self-confidence were 3.71 ± 0.88 and 3.70 ± 0.87, respectively. A strong positive correlation (<i>p</i> < 0.001) was found between satisfaction and self-confidence levels. The highest satisfaction and self-confidence scores were associated with the variety of learning materials and the instructors' helpfulness. <b>Conclusion:</b> The SBL intervention was effective in enhancing student satisfaction and self-confidence in critical care medicine. The strong correlation between satisfaction and self-confidence highlights the importance of well-designed SBL programs in preparing medical students for clinical practice in critical care settings.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2024 ","pages":"6908005"},"PeriodicalIF":1.8,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11511592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142510184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparison of the Outcomes of COVID-19 Vaccinated and Nonvaccinated Patients Admitted to an Intensive Care Unit in a Low-Middle-Income Country. 一个中低收入国家的重症监护病房收治的 COVID-19 疫苗接种患者与未接种患者的治疗效果比较。
IF 1.8 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-10-04 eCollection Date: 2024-01-01 DOI: 10.1155/2024/9571132
Waleed Bin Ghaffar, Muhammad Faisal Khan, Moeed Bin Abdul Ghaffar, Muhammad Sohaib, Asma Rayani, Muhammad Mehmood Alam, Syed Talha Sibtain, Zahra Cheema, Asad Latif

Patients critically afflicted with coronavirus disease 2019 (COVID-19) often need intensive care unit (ICU) admission, despite comprehensive vaccination campaigns. The challenges faced by healthcare systems in low-middle-income countries, including limited infrastructure and resources, play a pivotal role in shaping the outcomes for these patients. This study aimed to meticulously compare outcomes between COVID-19 vaccinated and nonvaccinated patients admitted to the ICU. In addition, demographic factors and the ICU course influencing mortality were also assessed. A retrospective review of records from the COVID-ICU of Aga Khan University Hospital spanning July 2021-March 2022 included 133 patients. Statistical analyses, encompassing the Mann-Whitney U-test and chi-square/Fisher exact test, discerned quantitative and qualitative differences. Stepwise multivariable logistic regression models with forward selection identified factors associated with hospital mortality. Results revealed comparable cohorts: vaccinated (48.13%) and nonvaccinated (51.87%). Vaccinated individuals, characterized by advanced age and higher Charlson Comorbidity Index, exhibited more critical disease (89.1%; p value: 0.06), acute respiratory distress syndrome (96.9%; p value: 0.013) and elevated inflammatory markers. Despite these differences, both cohorts exhibited similar overall outcomes. Factors such as decreased PaO2/FiO2 ratio on admission and complications during ICU stay were significantly associated with in-hospital mortality. In conclusion, despite advanced age and increased frailty among vaccinated patients, their mortality rate remained comparable to nonvaccinated counterparts. These findings underscore the pivotal role of vaccination in mitigating severe outcomes within this vulnerable population.

尽管开展了全面的疫苗接种活动,2019 年冠状病毒病(COVID-19)重症患者仍经常需要入住重症监护病房(ICU)。中低收入国家医疗系统面临的挑战,包括基础设施和资源有限,对这些患者的治疗效果起着关键作用。本研究旨在细致比较接种 COVID-19 疫苗和未接种疫苗的 ICU 患者的治疗效果。此外,还评估了影响死亡率的人口统计学因素和重症监护室病程。阿迦汗大学医院COVID-ICU对2021年7月至2022年3月期间的记录进行了回顾性审查,共纳入133名患者。统计分析包括曼-惠特尼U检验和秩方/费舍尔精确检验,可发现定量和定性差异。采用前向选择的逐步多变量逻辑回归模型确定了与住院死亡率相关的因素。结果显示,接种疫苗的人群(48.13%)和未接种疫苗的人群(51.87%)具有可比性。接种疫苗者的特点是高龄和夏尔森综合指数较高,表现出更多危重疾病(89.1%;P 值:0.06)、急性呼吸窘迫综合征(96.9%;P 值:0.013)和炎症标志物升高。尽管存在这些差异,但两组患者的总体预后相似。入院时PaO2/FiO2比值下降和重症监护室住院期间的并发症等因素与院内死亡率显著相关。总之,尽管接种疫苗的患者年龄偏大、体弱程度增加,但他们的死亡率仍与未接种疫苗的患者相当。这些研究结果强调了疫苗接种在减轻这一脆弱人群严重后果方面的关键作用。
{"title":"A Comparison of the Outcomes of COVID-19 Vaccinated and Nonvaccinated Patients Admitted to an Intensive Care Unit in a Low-Middle-Income Country.","authors":"Waleed Bin Ghaffar, Muhammad Faisal Khan, Moeed Bin Abdul Ghaffar, Muhammad Sohaib, Asma Rayani, Muhammad Mehmood Alam, Syed Talha Sibtain, Zahra Cheema, Asad Latif","doi":"10.1155/2024/9571132","DOIUrl":"https://doi.org/10.1155/2024/9571132","url":null,"abstract":"<p><p>Patients critically afflicted with coronavirus disease 2019 (COVID-19) often need intensive care unit (ICU) admission, despite comprehensive vaccination campaigns. The challenges faced by healthcare systems in low-middle-income countries, including limited infrastructure and resources, play a pivotal role in shaping the outcomes for these patients. This study aimed to meticulously compare outcomes between COVID-19 vaccinated and nonvaccinated patients admitted to the ICU. In addition, demographic factors and the ICU course influencing mortality were also assessed. A retrospective review of records from the COVID-ICU of Aga Khan University Hospital spanning July 2021-March 2022 included 133 patients. Statistical analyses, encompassing the Mann-Whitney U-test and chi-square/Fisher exact test, discerned quantitative and qualitative differences. Stepwise multivariable logistic regression models with forward selection identified factors associated with hospital mortality. Results revealed comparable cohorts: vaccinated (48.13%) and nonvaccinated (51.87%). Vaccinated individuals, characterized by advanced age and higher Charlson Comorbidity Index, exhibited more critical disease (89.1%; <i>p</i> value: 0.06), acute respiratory distress syndrome (96.9%; <i>p</i> value: 0.013) and elevated inflammatory markers. Despite these differences, both cohorts exhibited similar overall outcomes. Factors such as decreased PaO2/FiO2 ratio on admission and complications during ICU stay were significantly associated with in-hospital mortality. In conclusion, despite advanced age and increased frailty among vaccinated patients, their mortality rate remained comparable to nonvaccinated counterparts. These findings underscore the pivotal role of vaccination in mitigating severe outcomes within this vulnerable population.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2024 ","pages":"9571132"},"PeriodicalIF":1.8,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11469933/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142477420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dyschloremia and Renal Outcomes in Critically Ill Patients With Sepsis: A Prospective Cohort Study: Dyschloremia and Renal Outcomes in Sepsis. 脓毒症重症患者的溶血症和肾脏预后:一项前瞻性队列研究:脓毒症重症患者的溶血和肾功能结果:一项前瞻性队列研究
IF 1.8 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-10-01 eCollection Date: 2024-01-01 DOI: 10.1155/2024/8848405
Saurabh M Thanekar, Vishal Shanbhag, Attur Ravindra Prabhu, Shankar Prasad Nagaraju, Dharshan Rangaswamy, Srinivas Vinayak Shenoy, Mohan Varadarayanahalli Bhojaraja, Indu Ramachandra Rao

Introduction: Chloride is the most abundant extracellular anion; however, abnormalities of serum chloride (dyschloremia) are often overlooked. This study aimed to study the association of dyschloremia with AKI and major adverse kidney events at Day 30 (MAKE30) in critically ill patients with sepsis. Materials and Methods: This prospective single-center cohort study included adult patients with sepsis admitted in a tertiary care hospital in India. Patients with advanced chronic kidney disease, requiring dialysis at admission, or with hospital stay of less than 72 h were excluded. Hyperchloremia and hypochloremia were defined as chloride levels of > 110 mEq/L and < 95 mEq/L, respectively. The primary outcome measure was MAKE30-a composite of death, need for dialysis, or sustained loss of kidney function at Day 30. Results: In a cohort of 400 patients with a mean age of 60 (±15) years, AKI was seen in 301 (75.2%) and MAKE30 in 171 (42.8%). Hyperchloremia and hypochloremia were seen in 19.3% (n = 77) and 32.3% (n = 129), respectively, in the first 72 h of ICU stay. Hypochloremia, but not hyperchloremia, was independently associated with both MAKE30 (OR: 2.56, 95% CI: 1.13-5.79; p=0.024) and new-onset or worsening AKI (OR: 2.52, 95% CI: 1.17-5.41; p=0.019). There was no association between hyperchloremia and either MAKE30 (OR: 1.07, 95% CI: 0.43-2.69; p=0.882) or new-onset/worsening AKI (OR: 0.89, 95% CI: 0.38-2.09; p=0.781). Conclusion: Hypochloremia, but not hyperchloremia, was associated with MAKE30 in this cohort of critically ill patients with sepsis. Trial Registration: Clinical Trial Registry identifier: CTRI//2022/02/040519.

简介氯化物是细胞外最丰富的阴离子,但血清氯化物异常(血氯过高症)却常常被忽视。本研究旨在探讨脓毒症重症患者血清氯离子异常与 AKI 和第 30 天主要不良肾脏事件(MAKE30)之间的关系。材料与方法:这项前瞻性单中心队列研究纳入了印度一家三级医院收治的成年脓毒症患者。排除了患有晚期慢性肾病、入院时需要透析或住院时间少于 72 小时的患者。高氯血症和低氯血症的定义分别为氯化物水平> 110 mEq/L和< 110 mEq/L:在平均年龄为 60 (±15) 岁的 400 名患者中,301 人(75.2%)出现了 AKI,171 人(42.8%)出现了 MAKE30。在入住重症监护室的前 72 小时内,分别有 19.3% (77 人)和 32.3% (129 人)的患者出现高氯血症和低氯血症。低氯血症(而非高氯血症)与 MAKE30(OR:2.56,95% CI:1.13-5.79;P=0.024)和新发或恶化的 AKI(OR:2.52,95% CI:1.17-5.41;P=0.019)独立相关。高胆红素血症与 MAKE30(OR:1.07,95% CI:0.43-2.69;P=0.882)或新发/恶化的 AKI(OR:0.89,95% CI:0.38-2.09;P=0.781)之间没有关联。结论在这组脓毒症重症患者中,低氯血症(而非高氯血症)与 MAKE30 相关。试验注册:临床试验注册标识符:CTRI//2022/02/040519.
{"title":"Dyschloremia and Renal Outcomes in Critically Ill Patients With Sepsis: A Prospective Cohort Study: Dyschloremia and Renal Outcomes in Sepsis.","authors":"Saurabh M Thanekar, Vishal Shanbhag, Attur Ravindra Prabhu, Shankar Prasad Nagaraju, Dharshan Rangaswamy, Srinivas Vinayak Shenoy, Mohan Varadarayanahalli Bhojaraja, Indu Ramachandra Rao","doi":"10.1155/2024/8848405","DOIUrl":"https://doi.org/10.1155/2024/8848405","url":null,"abstract":"<p><p><b>Introduction:</b> Chloride is the most abundant extracellular anion; however, abnormalities of serum chloride (dyschloremia) are often overlooked. This study aimed to study the association of dyschloremia with AKI and major adverse kidney events at Day 30 (MAKE30) in critically ill patients with sepsis. <b>Materials and Methods:</b> This prospective single-center cohort study included adult patients with sepsis admitted in a tertiary care hospital in India. Patients with advanced chronic kidney disease, requiring dialysis at admission, or with hospital stay of less than 72 h were excluded. Hyperchloremia and hypochloremia were defined as chloride levels of > 110 mEq/L and < 95 mEq/L, respectively. The primary outcome measure was MAKE30-a composite of death, need for dialysis, or sustained loss of kidney function at Day 30. <b>Results:</b> In a cohort of 400 patients with a mean age of 60 (±15) years, AKI was seen in 301 (75.2%) and MAKE30 in 171 (42.8%). Hyperchloremia and hypochloremia were seen in 19.3% (<i>n</i> = 77) and 32.3% (<i>n</i> = 129), respectively, in the first 72 h of ICU stay. Hypochloremia, but not hyperchloremia, was independently associated with both MAKE30 (OR: 2.56, 95% CI: 1.13-5.79; <i>p</i>=0.024) and new-onset or worsening AKI (OR: 2.52, 95% CI: 1.17-5.41; <i>p</i>=0.019). There was no association between hyperchloremia and either MAKE30 (OR: 1.07, 95% CI: 0.43-2.69; <i>p</i>=0.882) or new-onset/worsening AKI (OR: 0.89, 95% CI: 0.38-2.09; <i>p</i>=0.781). <b>Conclusion:</b> Hypochloremia, but not hyperchloremia, was associated with MAKE30 in this cohort of critically ill patients with sepsis. <b>Trial Registration:</b> Clinical Trial Registry identifier: CTRI//2022/02/040519.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2024 ","pages":"8848405"},"PeriodicalIF":1.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus for the Development of a New Early Warning Score for Predicting Patients' Clinical Deterioration in Angola: A Delphi Study. 为预测安哥拉患者临床病情恶化而开发新预警评分的共识:德尔菲研究。
IF 1.8 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.1155/2024/9070807
Esmael Tomás, Ana Escoval, Maria Lina Antunes

Background: Nearly 30 years since its inception, the early warning scores (EWSs) remain pivotal, yet variations have emerged for hospital and prehospital use. Aggregated scores, reflecting multiple physiological parameters, outperform single-parameter systems in assessing acute illness severity, though consensus on optimal approaches is lacking. Resource-limited countries, including Angola, lack adapted EWSs, emphasizing the need for cost-effective and adaptable solutions to enhance patient care. Objective: To explore the perspectives of Angolan experts to identify physiological parameters suitable for incorporation into existing EWSs, allowing the development of a new tool adjusted to the healthcare context in Angola. Methods: We conducted a three-round Delphi survey, engaging a national expert panel comprising twenty-five physicians and nurses with expertise in internal medicine, surgery, emergency rooms, intensive care units, and/or teachers at universities or at teaching courses in these fields. Participants were asked to rate items using a five-point Likert scale. Consensus was achieved if the items received a rating ≥ 80% from the panel. Results: Consensus was evident for the inclusion of standard physiological parameters, such as systolic blood pressure, heart rate, respiratory rate, temperature, oxygen saturation, neurological status, and the presence or absence of supplemental oxygen. Furthermore, there was consensus for the consideration of specific items, namely, seizures, jaundice, cyanosis, capillary refill time, and pain-typically not included in the current EWSs. Consensus was reached regarding the exclusion of both oxygen saturation and temperature measurements in healthcare settings where oximeters and thermometers might not be readily available. Conclusion: Angolan experts were able to identify the physiological parameters suitable for incorporation into the basic EWSs. Further study must be conducted to test and validate the impact of the newly suggested vital parameters on the discriminant and predictive capability of a new aggregated model specifically adjusted to the Angolan healthcare setting.

背景:早期预警评分(EWS)自问世以来已近 30 年,但在医院和院前使用时出现了差异。在评估急性病严重程度方面,反映多种生理参数的综合评分优于单一参数系统,但对最佳方法尚未达成共识。包括安哥拉在内的资源有限国家缺乏适用的 EWS 系统,因此强调需要成本效益高、适应性强的解决方案来加强对患者的护理。目标:探讨安哥拉专家的观点,以确定适合纳入现有EWS的生理参数,从而开发出适合安哥拉医疗环境的新工具。研究方法我们进行了三轮德尔菲调查,邀请了25名内科、外科、急诊室、重症监护室的医生和护士,以及/或大学或这些领域教学课程的教师组成全国专家小组。参与者被要求使用五点李克特量表对项目进行评分。如果小组对项目的评分≥80%,则达成共识。结果:在纳入标准生理参数(如收缩压、心率、呼吸频率、体温、血氧饱和度、神经系统状态以及是否补充氧气)方面达成了明显的共识。此外,在考虑特定项目方面也达成了共识,即癫痫发作、黄疸、紫绀、毛细血管再充盈时间和疼痛--这些项目通常不包括在当前的 EWS 中。在血氧饱和度和体温测量不适用的医疗环境中,由于血氧饱和度和体温测量仪可能无法随时使用,这一点已达成共识。结论:安哥拉专家能够确定适合纳入基本预警系统的生理参数。必须开展进一步研究,以测试和验证新建议的生命参数对专门针对安哥拉医疗环境调整的新综合模型的判别和预测能力的影响。
{"title":"Consensus for the Development of a New Early Warning Score for Predicting Patients' Clinical Deterioration in Angola: A Delphi Study.","authors":"Esmael Tomás, Ana Escoval, Maria Lina Antunes","doi":"10.1155/2024/9070807","DOIUrl":"10.1155/2024/9070807","url":null,"abstract":"<p><p><b>Background:</b> Nearly 30 years since its inception, the early warning scores (EWSs) remain pivotal, yet variations have emerged for hospital and prehospital use. Aggregated scores, reflecting multiple physiological parameters, outperform single-parameter systems in assessing acute illness severity, though consensus on optimal approaches is lacking. Resource-limited countries, including Angola, lack adapted EWSs, emphasizing the need for cost-effective and adaptable solutions to enhance patient care. <b>Objective:</b> To explore the perspectives of Angolan experts to identify physiological parameters suitable for incorporation into existing EWSs, allowing the development of a new tool adjusted to the healthcare context in Angola. <b>Methods:</b> We conducted a three-round Delphi survey, engaging a national expert panel comprising twenty-five physicians and nurses with expertise in internal medicine, surgery, emergency rooms, intensive care units, and/or teachers at universities or at teaching courses in these fields. Participants were asked to rate items using a five-point Likert scale. Consensus was achieved if the items received a rating ≥ 80% from the panel. <b>Results:</b> Consensus was evident for the inclusion of standard physiological parameters, such as systolic blood pressure, heart rate, respiratory rate, temperature, oxygen saturation, neurological status, and the presence or absence of supplemental oxygen. Furthermore, there was consensus for the consideration of specific items, namely, seizures, jaundice, cyanosis, capillary refill time, and pain-typically not included in the current EWSs. Consensus was reached regarding the exclusion of both oxygen saturation and temperature measurements in healthcare settings where oximeters and thermometers might not be readily available. <b>Conclusion:</b> Angolan experts were able to identify the physiological parameters suitable for incorporation into the basic EWSs. Further study must be conducted to test and validate the impact of the newly suggested vital parameters on the discriminant and predictive capability of a new aggregated model specifically adjusted to the Angolan healthcare setting.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2024 ","pages":"9070807"},"PeriodicalIF":1.8,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11442038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142356158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of the Critical Care Resuscitation Unit on Quaternary Care Accessibility for Rural Patients: A Comparative Analysis. 重症监护复苏室对农村患者获得四级护理的影响:比较分析。
IF 1.8 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-08-22 eCollection Date: 2024-01-01 DOI: 10.1155/2024/9599855
Quincy K Tran, Anastasia Ternovskaia, Jessica V Downing, Minahil Cheema, Taylor Kowansky, Isha Vashee, Jasjot Sayal, Jasmine Wu, Aditi Singh, Daniel J Haase

Background: Previous research suggests that patients from rural areas who are critically ill with complex medical needs or require time-sensitive subspecialty interventions face worse healthcare outcomes and delays in care when compared to those from urban areas. The critical care resuscitation unit (CCRU) at our quaternary care center was established to expedite the transfer of critically ill patients or those who need time-sensitive intervention. This study investigates if disparities exist in treatments and outcomes among patients transferred to the CCRU from rural versus urban hospitals.

Methods: This is a retrospective study of adult, nontrauma patients admitted to the CCRU via interhospital transfer from outside facilities from January 1 to December 31, 2018. Patients transferred from within our institution or with missing clinical data were excluded. Multivariable logistic regressions were performed to measure the association between patients' demographic and clinical factors with in-hospital mortality.

Results: We analyzed 1381 nontrauma patients, and 484 (35%) were from rural areas. Median age was 59 [47-69], and 629 (46%) were female. Median sequential organ failure assessment was 3 ([1-6], p=0.062) for both patients transferred from urban and rural hospitals. There was no significant difference between groups with respect to most demographic and clinical factors, as well as types of interventions after CCRU arrival, including emergent surgical interventions within 12 hours of arrival at the CCRU. Rural patients were more likely to be transferred for care by the acute care emergency surgery service than were patients from urban areas and were transferred over a significantly greater distance (difference of 53 kilometers (km), 95% CI: -58.9-51.7 km, P < 0.001). Transfer from rural areas was not associated with increased odds of in-hospital mortality (OR: 0.90, 95% CI: 0.60, 1.36; P=0.63).

Conclusion: Thirty-five percent of patients transferred to the CCRU came from rural areas, which house 25% of the state population of Maryland. Patients transferred from rural counties to the CCRU faced greater transport distances, but they received the same level of care upon arrival at the CCRU and had the same odds of in-hospital mortality as patients transferred from urban hospitals.

背景:以往的研究表明,与来自城市地区的患者相比,来自农村地区的具有复杂医疗需求的危重病人或需要时间敏感的亚专科干预的患者面临着更差的医疗结果和护理延误。我们的四级医疗中心设立了重症监护复苏单元(CCRU),以加快危重病人或需要时间敏感性干预的病人的转院速度。本研究调查了从农村医院转入 CCRU 的患者与城市医院转入 CCRU 的患者在治疗和结果方面是否存在差异:这是一项回顾性研究,研究对象为2018年1月1日至12月31日期间通过院际转院从外部机构转入CCRU的成年非创伤患者。从本机构内部转院或临床数据缺失的患者被排除在外。我们对患者的人口统计学和临床因素与院内死亡率之间的关系进行了多变量逻辑回归:我们分析了 1381 名非创伤患者,其中 484 人(35%)来自农村地区。中位年龄为 59 岁 [47-69],629 人(46%)为女性。转自城市医院和农村医院的患者器官功能衰竭评估中位数均为 3([1-6],P=0.062)。在大多数人口统计学和临床因素以及到达 CCRU 后的干预类型(包括到达 CCRU 后 12 小时内的紧急外科干预)方面,两组之间没有明显差异。与来自城市地区的患者相比,农村患者更有可能转到急诊外科接受治疗,而且转院距离明显更远(相差53公里,95% CI:-58.9-51.7公里,P<0.001)。从农村地区转院与院内死亡率的增加无关(OR:0.90,95% CI:0.60,1.36;P=0.63):35%转入CCRU的患者来自农村地区,而农村地区人口占马里兰州总人口的25%。从农村地区转入CCRU的患者面临着更远的转运距离,但他们在到达CCRU后得到的护理水平相同,院内死亡率与从城市医院转入的患者相同。
{"title":"The Impact of the Critical Care Resuscitation Unit on Quaternary Care Accessibility for Rural Patients: A Comparative Analysis.","authors":"Quincy K Tran, Anastasia Ternovskaia, Jessica V Downing, Minahil Cheema, Taylor Kowansky, Isha Vashee, Jasjot Sayal, Jasmine Wu, Aditi Singh, Daniel J Haase","doi":"10.1155/2024/9599855","DOIUrl":"10.1155/2024/9599855","url":null,"abstract":"<p><strong>Background: </strong>Previous research suggests that patients from rural areas who are critically ill with complex medical needs or require time-sensitive subspecialty interventions face worse healthcare outcomes and delays in care when compared to those from urban areas. The critical care resuscitation unit (CCRU) at our quaternary care center was established to expedite the transfer of critically ill patients or those who need time-sensitive intervention. This study investigates if disparities exist in treatments and outcomes among patients transferred to the CCRU from rural versus urban hospitals.</p><p><strong>Methods: </strong>This is a retrospective study of adult, nontrauma patients admitted to the CCRU via interhospital transfer from outside facilities from January 1 to December 31, 2018. Patients transferred from within our institution or with missing clinical data were excluded. Multivariable logistic regressions were performed to measure the association between patients' demographic and clinical factors with in-hospital mortality.</p><p><strong>Results: </strong>We analyzed 1381 nontrauma patients, and 484 (35%) were from rural areas. Median age was 59 [47-69], and 629 (46%) were female. Median sequential organ failure assessment was 3 ([1-6], <i>p</i>=0.062) for both patients transferred from urban and rural hospitals. There was no significant difference between groups with respect to most demographic and clinical factors, as well as types of interventions after CCRU arrival, including emergent surgical interventions within 12 hours of arrival at the CCRU. Rural patients were more likely to be transferred for care by the acute care emergency surgery service than were patients from urban areas and were transferred over a significantly greater distance (difference of 53 kilometers (km), 95% CI: -58.9-51.7 km, <i>P</i> < 0.001). Transfer from rural areas was not associated with increased odds of in-hospital mortality (OR: 0.90, 95% CI: 0.60, 1.36; <i>P</i>=0.63).</p><p><strong>Conclusion: </strong>Thirty-five percent of patients transferred to the CCRU came from rural areas, which house 25% of the state population of Maryland. Patients transferred from rural counties to the CCRU faced greater transport distances, but they received the same level of care upon arrival at the CCRU and had the same odds of in-hospital mortality as patients transferred from urban hospitals.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2024 ","pages":"9599855"},"PeriodicalIF":1.8,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive Value of Red Cell Distribution Width-to-Platelet Ratio Combined with Procalcitonin in 28-day Mortality for Patients with Sepsis. 红细胞分布宽度与血小板比值结合降钙素原对败血症患者 28 天死亡率的预测价值。
IF 1.8 Q3 CRITICAL CARE MEDICINE Pub Date : 2024-08-12 eCollection Date: 2024-01-01 DOI: 10.1155/2024/9964992
Ying Si, Bo Sun, Yongmao Huang, Ke Xiao

Objectives: The objective of this study was to investigate the predictive value of erythrocyte distribution width-to-platelet ratio (RPR) combined with procalcitonin (PCT) on 28-day mortality in patients with sepsis.

Methods: A total of 193 patients with sepsis admitted to the Affiliated Hospital of Southwest Medical University from January 2013 to January 2018 were selected as the study objects. Univariate and multivariate analyses were used to understand the indicators related to the 28-day prognosis of patients, and the ROC curve was further drawn. The Kaplan-Meier curve was used to evaluate the prognosis of patients.

Results: A total of 193 patients were enrolled and divided into the survivor group (=156) and nonsurvivor group (=37) according to the prognosis within 28 days. The median age was 62.5 years, and 64.7% were males. Multivariate analysis showed that PCT and RPR were independent risk factors for 28-day prognosis in sepsis patients. The area under the ROC curve of PCT and RPR were 0.894 and 0.861, respectively, and the cutoff values were 27.04 and 0.12, respectively. Survival curve analysis showed that PCT and RPR were associated with the 28-day prognosis of patients, and the combination of PCT and RPR had a better predictive effect.

Conclusions: PCT and RPR are independent predictors of sepsis prognosis. The combined application of PCT and RPR (PCT-RPR) can further improve the predictive performance and provide a reference for the clinical diagnosis, treatment, and prognosis evaluation of sepsis patients.

研究目的本研究旨在探讨红细胞分布宽度与血小板比值(RPR)联合降钙素原(PCT)对败血症患者28天死亡率的预测价值:选取2013年1月至2018年1月西南医科大学附属医院收治的脓毒症患者共193例作为研究对象。采用单变量和多变量分析了解患者28天预后的相关指标,并进一步绘制ROC曲线。结果:共纳入 193 例患者,根据 28 天内的预后分为存活组(=156)和非存活组(=37)。中位年龄为 62.5 岁,64.7% 为男性。多变量分析显示,PCT 和 RPR 是影响败血症患者 28 天预后的独立风险因素。PCT和RPR的ROC曲线下面积分别为0.894和0.861,临界值分别为27.04和0.12。生存曲线分析表明,PCT和RPR与患者28天的预后相关,PCT和RPR的组合具有更好的预测效果:结论:PCT和RPR是脓毒症预后的独立预测指标。结论:PCT 和 RPR 是预测脓毒症预后的独立指标,联合应用 PCT 和 RPR(PCT-RPR)可进一步提高预测效果,为脓毒症患者的临床诊断、治疗和预后评估提供参考。
{"title":"Predictive Value of Red Cell Distribution Width-to-Platelet Ratio Combined with Procalcitonin in 28-day Mortality for Patients with Sepsis.","authors":"Ying Si, Bo Sun, Yongmao Huang, Ke Xiao","doi":"10.1155/2024/9964992","DOIUrl":"10.1155/2024/9964992","url":null,"abstract":"<p><strong>Objectives: </strong>The objective of this study was to investigate the predictive value of erythrocyte distribution width-to-platelet ratio (RPR) combined with procalcitonin (PCT) on 28-day mortality in patients with sepsis.</p><p><strong>Methods: </strong>A total of 193 patients with sepsis admitted to the Affiliated Hospital of Southwest Medical University from January 2013 to January 2018 were selected as the study objects. Univariate and multivariate analyses were used to understand the indicators related to the 28-day prognosis of patients, and the ROC curve was further drawn. The Kaplan-Meier curve was used to evaluate the prognosis of patients.</p><p><strong>Results: </strong>A total of 193 patients were enrolled and divided into the survivor group (=156) and nonsurvivor group (=37) according to the prognosis within 28 days. The median age was 62.5 years, and 64.7% were males. Multivariate analysis showed that PCT and RPR were independent risk factors for 28-day prognosis in sepsis patients. The area under the ROC curve of PCT and RPR were 0.894 and 0.861, respectively, and the cutoff values were 27.04 and 0.12, respectively. Survival curve analysis showed that PCT and RPR were associated with the 28-day prognosis of patients, and the combination of PCT and RPR had a better predictive effect.</p><p><strong>Conclusions: </strong>PCT and RPR are independent predictors of sepsis prognosis. The combined application of PCT and RPR (PCT-RPR) can further improve the predictive performance and provide a reference for the clinical diagnosis, treatment, and prognosis evaluation of sepsis patients.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2024 ","pages":"9964992"},"PeriodicalIF":1.8,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11333126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Critical Care Research and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1